JPH0580044A - Blood separation agent and blood separation tube - Google Patents

Blood separation agent and blood separation tube

Info

Publication number
JPH0580044A
JPH0580044A JP3268746A JP26874691A JPH0580044A JP H0580044 A JPH0580044 A JP H0580044A JP 3268746 A JP3268746 A JP 3268746A JP 26874691 A JP26874691 A JP 26874691A JP H0580044 A JPH0580044 A JP H0580044A
Authority
JP
Japan
Prior art keywords
viscosity
blood
agent
separation
forming material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP3268746A
Other languages
Japanese (ja)
Other versions
JP2943454B2 (en
Inventor
Jun Satake
順 佐武
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Ink Mfg Co Ltd
Original Assignee
Toyo Ink Mfg Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Ink Mfg Co Ltd filed Critical Toyo Ink Mfg Co Ltd
Priority to JP3268746A priority Critical patent/JP2943454B2/en
Priority to EP92306176A priority patent/EP0521733B1/en
Priority to DE69213847T priority patent/DE69213847T2/en
Publication of JPH0580044A publication Critical patent/JPH0580044A/en
Priority to US08/340,456 priority patent/US5505853A/en
Application granted granted Critical
Publication of JP2943454B2 publication Critical patent/JP2943454B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a blood separation agent excellent in practice by using a separation layer forming material, a lipophilic laminar inorganic based com pound and a viscosity applying agent. CONSTITUTION:A separation layer forming material herein used has a specific weight in an intermediate range between a serum component and a blood cell component and a high polymer oil-like matter with the viscosity at 25 deg.C in a range of 200-600,000 CPS is suitable, for example, silicone and chlorinated polybutene. A lipophilic laminar inorganic based compound brings low and medium molecular organic compound between layers to expand easily and with high thixotropy, it is added to the separation forming material at a rate of 0.1-5 pts.wt. per 100 pts.wt. thereof. A viscosity applying agent such as rosin or dammar is blended into a high polymer oil-like matter to improve adhesiveness and wettability with an object to be applied. The agent is added to the separation forming material at the ratio of 0.1-60 pts.wt. per 100 pts.wt. thereof. In the preferable physical property of compositions as mentioned above composing a blood separation material, specific gravity at 25 deg.C is intermediate between the serum and blood cell, namely, 1.035-1.06 and the viscosity is appropriately in a range of 200,000-2,000,000 CPS.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、血液分離剤に関する。
より詳しくは血液中の血清部分と血餅部分、あるいは血
漿部分と血球部分とをその比重差により分離する際、両
成分の中間的な比重を付与する事により両成分の間に隔
壁を形成せしめ、これら両成分の分離操作を容易にする
目的に使用し得る血液分離剤およびこれを有底管内に収
容してなる血液分離管に関する。
TECHNICAL FIELD The present invention relates to a blood separating agent.
More specifically, when separating the serum part and blood clot part in blood, or the plasma part and blood cell part by their specific gravity differences, a partition wall is formed between both components by giving an intermediate specific gravity of both components. The present invention relates to a blood separating agent that can be used for the purpose of facilitating the separation operation of these both components, and a blood separating tube containing the same in a bottomed tube.

【0002】[0002]

【従来の技術】従来、血液の分離操作に用いられる分離
剤としては、シリコ−ンオイル、塩素化ポリブテン、ポ
リイソブテン、アクリル重合体、α−オレフィン/マレ
イン酸ジエステル重合体などの樹脂を主成分として、こ
れらに比重、粘度調製用としてシリカ、粘土等の無機微
粒子や有機ゲル化剤を添加したものがあった。これら、
主成分となる樹脂は基本的に疎水性を有するものであ
り、また、無機微粒子は増粘効果、チキソトロピ−性付
与を与え、有機ゲル化剤は、チキソトロピ−性を付与す
ることなく、増粘効果を与えるものである。
2. Description of the Related Art Conventionally, as a separating agent used for separating blood, a resin such as silicone oil, chlorinated polybutene, polyisobutene, an acrylic polymer or an α-olefin / maleic acid diester polymer is used as a main component. In some of these, inorganic fine particles such as silica and clay or an organic gelling agent were added for adjusting specific gravity and viscosity. these,
The resin as the main component is basically hydrophobic, and the inorganic fine particles give a thickening effect and a thixotropy imparting property, and the organic gelling agent thickens without imparting the thixotropy property. It gives an effect.

【0003】しかし、これら主成分となる樹脂は、液状
であり、有底管内に収容した分離管を横置きにして保存
すると、経時で分離剤が流れ出し、実用的でない。この
ような欠点を補うため、微粉砕マイカ、コロイダルシリ
カなどのチキソトロピ−付与剤や、有機ゲル化剤などを
添加している。しかし、チキソトロピ−付与剤を添加し
た系では、室温においてはチキソトロピ−性があり保存
の際の流れは押さえられるが、高温下ではチキソトロピ
−性が減少し、また、粘度も低くなるために、分離剤が
流れてしまう。また、有機ゲル化剤を添加した系は、室
温、高温下において流れは押さえられるが、経時で増粘
し、分離剤としての性能が低下するという欠点があっ
た。
However, the resins as the main components are liquid, and if the separation tube housed in the bottomed tube is stored horizontally, the separating agent will flow out over time, which is not practical. In order to compensate for such drawbacks, a thixotropic agent such as finely pulverized mica and colloidal silica, an organic gelling agent and the like are added. However, in a system to which a thixotropy-imparting agent is added, it has thixotropy at room temperature and can suppress the flow at the time of storage, but at high temperature the thixotropy is reduced and the viscosity is also low, so that separation The agent will flow. Further, the system to which the organic gelling agent is added has a drawback that the flow is suppressed at room temperature and high temperature, but the viscosity as time passes and the performance as a separating agent is deteriorated.

【0004】[0004]

【発明が解決しようとする課題】本発明の目的は、これ
らの欠点のない、実用性に優れた血液分離剤およびそれ
を有底管内に収容して得られる血液分離管を提供するこ
とにある。 本発明者らは、かかる目的を達成するため
に鋭意検討を重ねた結果、分離層形成材料に親油性層状
無機系化合物と粘着付与剤とを共存させることにより温
度に関わらずに流れを防止することを見いだし本発明に
至った。
SUMMARY OF THE INVENTION It is an object of the present invention to provide a blood separating agent which is free from these drawbacks and which is excellent in practical use, and a blood separating tube which is obtained by accommodating the blood separating agent in a bottomed tube. .. As a result of intensive studies to achieve such an object, the present inventors prevent the flow regardless of temperature by coexisting a lipophilic layered inorganic compound and a tackifier in a separation layer forming material. The present invention has been discovered and the present invention has been achieved.

【0005】[0005]

【課題を解決するための手段】即ち、本発明は、分離層
形成材料、親油性層状無機系化合物および粘着付与剤を
含む血液分離剤であり、さらには該血液分離剤を有底管
内に収容してなる血液分離管であある。
That is, the present invention is a blood separating agent containing a separating layer forming material, a lipophilic layered inorganic compound and a tackifier, and further, the blood separating agent is housed in a bottomed tube. It is a blood separation tube made of.

【0006】以下、本発明について詳細に説明する。本
発明の血液分離剤に用いる分離層成形材料としては、そ
の比重が血清成分と血球成分との中間領域にあるもので
あれば、低粘度の各種有機溶剤や可塑剤から高粘度の高
分子油状物まで使用することができる。実用上、安定で
適度な流動性およびゲル化性を与える点で、好ましくは
温度25℃での粘度が200〜60万cpsの範囲の高
分子油状物が適している。かかる高分子油状物として
は、例えば、シリコ−ン、塩素化ポリブテン、塩素化ポ
リブタジエン、ポリ(メタ)アクリル酸エステル、ポリ
イソブテン、α−オレフィンまたはスチレンとマレイン
酸ジエステルとの共重合体などが挙げられる。
The present invention will be described in detail below. As the separation layer molding material used for the blood separating agent of the present invention, as long as its specific gravity is in the intermediate region between the serum component and the blood cell component, a high-viscosity polymer oil from various low-viscosity organic solvents or plasticizers Even things can be used. Practically, a polymer oil having a viscosity in the range of 200 to 600,000 cps at a temperature of 25 ° C. is preferable from the viewpoint of providing stable and appropriate fluidity and gelation property. Examples of such polymer oils include silicone, chlorinated polybutene, chlorinated polybutadiene, poly (meth) acrylic acid ester, polyisobutene, α-olefin or a copolymer of styrene and maleic acid diester. ..

【0007】本発明の血液分離剤に用いる親油性層状無
機系化合物とは、天然、合成のマイカ、雲母、ベントナ
イト、スメクタイト等の粘土鉱物の層間にある金属イオ
ンを、アルキルアンモニウム塩などの親油基を持つオニ
ウム塩に置換したものである。これら親油性層状無機系
化合物は、低、中分子状の有機化合物を層間に取り込
み、容易に膨潤する。これにより、高いチキソトロピ−
性をもたせることができる。さらに、温度変化により、
吸油性が変わり、温度変化によるチキソトロピ−性の変
化を小さくすることが可能である。これら親油性層状無
機系化合物は、分離剤の粘度、比重を考慮して配合しな
ければならないが、通常は分離層形成材料100重量部
に対して0.1〜5重量部添加することが望ましい。親
油性層状無機系化合物の添加量が少なすぎると、充分な
チキソトロピ−性を付与できず、流れの原因となる。ま
た該添加量が多すぎると、粘度や比重が上昇し、実用に
即さない。
The lipophilic layered inorganic compound used in the blood separating agent of the present invention means a metal ion existing between clay minerals such as natural and synthetic mica, mica, bentonite and smectite, and lipophilic oil such as alkyl ammonium salt. It is an onium salt having a group. These lipophilic layered inorganic compounds take in low- and medium-molecular-weight organic compounds between layers and easily swell. This makes high thixotropy
You can have sex. Furthermore, due to temperature changes,
The oil absorbency changes, and it is possible to reduce the change in thixotropy due to temperature change. These lipophilic layered inorganic compounds must be blended in consideration of the viscosity and specific gravity of the separating agent, but normally it is desirable to add 0.1 to 5 parts by weight to 100 parts by weight of the separating layer forming material. .. If the amount of the lipophilic layered inorganic compound added is too small, sufficient thixotropy cannot be imparted, which causes flow. On the other hand, if the amount added is too large, the viscosity and specific gravity increase, which is not suitable for practical use.

【0008】本発明の血液分離剤に用いる粘着付与剤と
は、一般に熱可塑性であり、常温で固形ないし半固形
で、5〜150℃程度の軟化点を有し、分子量約200
〜1500程度である。これら粘着付与剤は、高分子油
状物中に配合することにより、粘弾性的、界面的に作用
し、被着体との接着性、濡れ性を飛躍的に向上させる。
これら粘着付与剤は、大きく、天然樹脂系粘着付与剤と
合成樹脂系粘着付与剤とにわかれる。なお、粘着付与剤
は、ポリマ−に添加され、粘着性(タッキネス)を付与
する配合剤であり、ガラス転移点、軟化点が共に低く、
流動性を与えるものが多い。
The tackifier used in the blood separating agent of the present invention is generally thermoplastic, is solid or semi-solid at room temperature, has a softening point of about 5 to 150 ° C., and has a molecular weight of about 200.
It is about 1500. By blending these tackifiers in a polymer oil, they act viscoelastically and interfacially, and dramatically improve the adhesiveness and wettability with the adherend.
These tackifiers are largely classified into natural resin tackifiers and synthetic resin tackifiers. The tackifier is a compounding agent that is added to the polymer to impart tackiness, and has a low glass transition point and a low softening point,
Many give liquidity.

【0009】天然樹脂系粘着付与剤としては、例えばロ
ジン、ダンマル、重合ロジン、部分水添ロジン、グリセ
リンエステルロジン、グリセリンエステルロジン部分水
添物、グリセリンエステルロジン完全水添物、重合グリ
セリンエステルロジン、ペンタエリスリットエステルロ
ジン、部分水添ペンタエリスリットエステルロジン、重
合ペンタエリスリットエステルロジン、α−ピネン、β
−ピネンの重合体、ジペンテン重合体などのポリテルペ
ン系樹脂、ポリテルペン系樹脂の水添物、テルペンフェ
ノ−ル等が挙げられる。合成樹脂系粘着付与剤として
は、オレフィンおよびジオレフィン重合体、シクロペン
タジエン樹脂、芳香族系石油樹脂、芳香族系樹脂の水添
物、フェノール樹脂、アルキルフェノ−ル−アセチレン
系樹脂、スチレン系樹脂、キシレン系樹脂、クマロンイ
ンデン樹脂、ビニルトルエン−α−メチルスチレン共重
合体樹脂等が挙げられる。 これら粘着付与剤は、分離
層形成材料との相溶性、粘度等を考慮して配合しなけれ
ばならないが、通常は分離層形成材料100重量部に対
して0.1〜60重量部、好ましくは1〜30重量部添
加することが望ましい。粘着付与剤の添加量が少なすぎ
ると、親油性層状無機系化合物に対する吸油量が少な
く、充分なチキソトロピ−性が得られない。また該添加
量が多すぎると、相溶性が悪くなり、分離に至ったり、
粘度が上昇して遠心分離に弊害を及ぼす。
Examples of natural resin tackifiers include rosin, dammar, polymerized rosin, partially hydrogenated rosin, glycerin ester rosin, glycerin ester rosin partially hydrogenated product, glycerin ester rosin complete hydrogenated product, polymerized glycerine ester rosin, Pentaerythritol ester rosin, partially hydrogenated pentaerythritol ester rosin, polymerized pentaerythritol ester rosin, α-pinene, β
-Polyene polymers such as pinene polymers and dipentene polymers, hydrogenated products of polyterpene resins, and terpene phenols. Synthetic resin-based tackifiers include olefin and diolefin polymers, cyclopentadiene resins, aromatic petroleum resins, hydrogenated aromatic resins, phenol resins, alkylphenol-acetylene resins, styrene resins. , Xylene-based resin, coumarone-indene resin, vinyltoluene-α-methylstyrene copolymer resin and the like. These tackifiers must be blended in consideration of compatibility with the separation layer forming material, viscosity, etc., but usually 0.1 to 60 parts by weight, preferably 100 parts by weight of the separating layer forming material, preferably It is desirable to add 1 to 30 parts by weight. If the addition amount of the tackifier is too small, the amount of oil absorption to the lipophilic layered inorganic compound is small and sufficient thixotropy cannot be obtained. Further, if the addition amount is too large, the compatibility becomes poor, leading to separation,
Viscosity increases, which adversely affects centrifugation.

【0010】本発明の血液分離剤を構成する組成物の好
適な物性は、温度25℃における比重が血清と血球との
中間、即ち1.035〜1.060であり、粘度は20
万〜200万cpsの範囲が適当である。本発明による
血液分離剤は場合により、シリカ、タルク、アルミナ等
の無機粉末、ワックス、可塑剤、ゲル化剤などの有機添
加物、血液凝固剤等を適宜添加しても良い。 本発明の
血液分離剤の製造方法としては、分離層成形材料を温度
80〜200℃に加熱し、これに親油性層状無機系化合
物、粘着付与剤を所定量添加し、数時間加熱撹拌する
か、またはロ−ルで分散させる方法がる。
The preferred physical properties of the composition constituting the blood separating agent of the present invention are that the specific gravity at a temperature of 25 ° C. is between serum and blood cells, ie, 1.035 to 1.060, and the viscosity is 20.
The range of 10,000 to 2,000,000 cps is suitable. The blood separating agent according to the present invention may optionally contain inorganic powders such as silica, talc and alumina, organic additives such as wax, plasticizer and gelling agent, blood coagulant and the like. As the method for producing the blood separating agent of the present invention, the separating layer molding material is heated to a temperature of 80 to 200 ° C., a predetermined amount of the lipophilic layered inorganic compound and the tackifier are added thereto, and the mixture is heated and stirred for several hours. Alternatively, there is a method of dispersing with a roll.

【0011】次に本発明を実施例により更に具体的に説
明するが、本発明はその要旨を越えない限り以下の実施
例によって限定されるものではない。また、実施例中、
特に記載がない限り、「部」は重量部を表す。
Next, the present invention will be described more specifically by way of examples, but the present invention is not limited to the following examples unless it exceeds the gist. In the examples,
Unless otherwise specified, "part" represents part by weight.

【0012】実施例1 4つ口フラスコに炭素数12および14の混合α−オレ
フィンとマレイン酸ジメチルエステル共重合体100
部、ペンタリンH(部分水添ロジンのペンタエリスリト
−ルエステル:理化ハ−キュレス社製)5部を仕込み、
100℃1時間撹拌混合した。このものは、ベントン3
8(アルキルアンモニウム変性天然スメクタイト:NL
インダストリ−社製)2部とともに3本ロ−ルにより混
練りし、粘度40万cps,比重1.040の血液分離
剤を得た。得られた分離剤は、15cc試験管の管底に
1.5gいれ、横倒しにして60℃の乾燥器中に4日間
放置したところ、流れが2mm以下であった。
Example 1 A mixed α-olefin having 12 and 14 carbon atoms and a maleic acid dimethyl ester copolymer 100 were placed in a four-necked flask.
Part, 5 parts of pentaline H (pentaerythritol ester of partially hydrogenated rosin: manufactured by Rika Hercules),
The mixture was stirred and mixed at 100 ° C. for 1 hour. This is Benton 3
8 (Alkyl ammonium modified natural smectite: NL
2 parts of Industrie Co., Ltd. and three parts were kneaded together to obtain a blood separating agent having a viscosity of 400,000 cps and a specific gravity of 1.040. The obtained separating agent was put in the bottom of a 15 cc test tube in an amount of 1.5 g, and was placed sideways in a dryer at 60 ° C. for 4 days. As a result, the flow was 2 mm or less.

【0013】実施例2 4つ口フラスコに分子量約1000のポリイソブテン1
00部、ステベライト10(部分水添ロジンのグリセリ
ンエステル:理化ハ−キュレス社製)5部を仕込み、1
00℃1時間撹拌混合した。このものは、ベントン38
(アルキルアンモニウム変性天然スメクタイト:NLイ
ンダストリ−社製)3部とともに3本ロ−ルにより混練
りし、粘度40万cps,比重1.048の血液分離剤
を得た。得られた分離剤は、15cc試験管の管底に
1.5gいれ、横倒しにして60℃の乾燥器中に4日間
放置したところ、流れが2mm以下であった。
Example 2 Polyisobutene 1 having a molecular weight of about 1000 was placed in a four-necked flask.
Charge 100 parts of steberite 10 (5 parts of glycerin ester of partially hydrogenated rosin: manufactured by Rika Hercules) and
The mixture was stirred and mixed at 00 ° C. for 1 hour. This is Benton 38
(Alkyl ammonium modified natural smectite: manufactured by NL Industry Co., Ltd.) and 3 parts were kneaded together to obtain a blood separating agent having a viscosity of 400,000 cps and a specific gravity of 1.048. The obtained separating agent was put in the bottom of a 15 cc test tube in an amount of 1.5 g, and was placed sideways in a dryer at 60 ° C. for 4 days. As a result, the flow was 2 mm or less.

【0014】実施例3 炭素数12および14の混合α−オレフィンとマレイン
酸ジメチルエステル共重合体100部とYSレジンPx
#1000(テレピン系樹脂:安原油脂工業社製)20
部とCR−TS(アルキルアンモニウム変性雲母:トピ
ー工業社製)2部とを3本ロ−ルで混練りし、粘度50
万cps,比重1.042の血液分離剤を得た。得られ
た分離剤は、15cc試験管に1.5gいれ、横倒しに
して60℃の乾燥器中に4日間放置したところ、流れが
1mm以下であった。
Example 3 Mixed α-olefin having 12 and 14 carbon atoms, 100 parts of maleic acid dimethyl ester copolymer and YS resin Px
# 1000 (Terpine resin: Yasuhara Yushi Kogyo Co., Ltd.) 20
And 3 parts of CR-TS (alkylammonium-modified mica: manufactured by Topy Industries, Ltd.) were kneaded with 3 rolls to give a viscosity of 50.
A blood separating agent with 10,000 cps and a specific gravity of 1.042 was obtained. The obtained separating agent was placed in a 15 cc test tube in an amount of 1.5 g, and was placed sideways in a dryer at 60 ° C. for 4 days. As a result, the flow was 1 mm or less.

【0015】比較例1 炭素数12および14の混合α−オレフィンとマレイン
酸ジメチルエステル共重合体100部とベントン38
(アルキルアンモニウム変性天然スメクタイト:NLイ
ンダストリ−社製)2.2部、コロイダルシリカ0.5
部を3本ロ−ルで混練りし、粘度60万cps,比重
1.045の血液分離剤を得た。得られた分離剤は、1
5cc試験管に1.5gいれ、横倒しにして60℃の乾
燥器中に1日間放置したところ、流れが8mmであっ
た。
Comparative Example 1 100 parts of a mixed α-olefin having 12 and 14 carbon atoms, a dimethyl ester of maleic acid copolymer and 38 of benton.
(Alkyl ammonium modified natural smectite: manufactured by NL Industry Co., Ltd.) 2.2 parts, colloidal silica 0.5
The parts were kneaded with three rolls to obtain a blood separating agent having a viscosity of 600,000 cps and a specific gravity of 1.045. The separating agent obtained is 1
When 1.5 g was put in a 5 cc test tube and laid down and left in a dryer at 60 ° C. for 1 day, the flow was 8 mm.

【0016】比較例2 炭素数12および14の混合α−オレフィンとマレイン
酸ジメチルエステル共重合体100部とペンタリンH
(部分水添ロジンのペンタエリスリト−ルエステル:理
化ハ−キュレス社製)40部を4つ口フラスコに仕込
み、100℃2時間撹拌混合し、粘度200万cps,
比重1.035の血液分離剤を得た。得られた分離剤
は、15cc試験管に1.5gいれ、横倒しにして室温
で1日間放置したところ、流れが60mmであった。
Comparative Example 2 100 parts of a mixed α-olefin having 12 and 14 carbon atoms, a dimethyl ester of maleic acid copolymer and pentaline H
(Partially hydrogenated rosin pentaerythritol ester: manufactured by Rika Hercules Co., Ltd.) 40 parts was placed in a four-necked flask and mixed with stirring at 100 ° C. for 2 hours to give a viscosity of 2,000,000 cps.
A blood separating agent having a specific gravity of 1.035 was obtained. The obtained separating agent was placed in a 15 cc test tube in an amount of 1.5 g, and when it was laid down and left standing at room temperature for 1 day, the flow was 60 mm.

【0017】比較例3 炭素数12および14の混合α−オレフィンとマレイン
酸ジメチルエステル共重合体100部とゲルオ−ルD
(ソルビト−ルとベンズアルデヒドとの縮合物、有機ゲ
ル化剤:新日本理化社製)0.5部とを3本ロ−ルで混
練りし、比重1.050、粘度50万cpsの血液分離
剤を得た。得られた分離剤は、15cc試験管に1.5
gいれ、横倒しにして60℃の乾燥器中に4日間放置し
たところ、流れが1mm以下であったが、このものは、
経時で粘度が上昇し、1年後には遠心分離しても完全に
流動しなくなった。
Comparative Example 3 100 parts of a mixed α-olefin having 12 and 14 carbon atoms, a dimethyl ester of maleic acid copolymer and Gelol D
0.5 parts (condensate of sorbitol and benzaldehyde, organic gelling agent: manufactured by Shin Nippon Rika Co., Ltd.) were kneaded with 3 rolls, and blood was separated with a specific gravity of 1.050 and a viscosity of 500,000 cps. I got an agent. The obtained separating agent is 1.5 in a 15 cc test tube.
It was placed in a dryer at 60 ° C. for 4 days, and the flow was less than 1 mm.
The viscosity increased with time, and after one year, it completely stopped flowing even after centrifugation.

【0018】[0018]

【発明の効果】本発明の血液分離剤は親油性層状無機系
化合物と粘着付与剤を併用しない従来の無機粉末、また
は有機ゲル化剤等を配合した血液分離剤と比較して、室
温時、および加熱時の経時での流れが少なく、また、経
時での粘度変化が少ない。これは、従来の血液分離剤に
ない温度に左右されないチキソトロピ−性を有し、その
ため粘度が高くなくても、経時で分離剤の形状を変える
ものでなく、また、粘度の経時変化もないために、物
性、安定性に優れた採血管を提供できる。
EFFECTS OF THE INVENTION The blood separating agent according to the present invention has a room temperature, compared with a conventional inorganic powder which does not use a lipophilic layered inorganic compound and a tackifier together, or a blood separating agent containing an organic gelling agent. Also, there is little flow over time during heating, and there is little change in viscosity over time. It has a thixotropic property that is not affected by temperature, which is not present in conventional blood separating agents, and therefore, even if the viscosity is not high, it does not change the shape of the separating agent with time, nor does it change with time. In addition, a blood collection tube having excellent physical properties and stability can be provided.

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】分離層形成材料、親油性層状無機系化合物
および粘着付与剤を含むことを特徴とする血液分離剤。
1. A blood separating agent comprising a separating layer forming material, a lipophilic layered inorganic compound and a tackifier.
【請求項2】請求項1記載の血液分離剤が、25℃にお
ける比重が1.030〜1.060であることを特徴と
する血液分離剤。
2. The blood separating agent according to claim 1, which has a specific gravity at 25 ° C. of 1.030 to 1.060.
【請求項3】請求項1記載の血液分離剤を有底管内に収
容してなる血液分離管。
3. A blood separation tube containing the blood separation agent according to claim 1 in a bottomed tube.
JP3268746A 1991-07-05 1991-09-20 Blood separation agent and blood separation tube Expired - Fee Related JP2943454B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP3268746A JP2943454B2 (en) 1991-09-20 1991-09-20 Blood separation agent and blood separation tube
EP92306176A EP0521733B1 (en) 1991-07-05 1992-07-03 Serum:plasma separator and tube containing the same
DE69213847T DE69213847T2 (en) 1991-07-05 1992-07-03 Serum / plasma separator and tube containing them
US08/340,456 US5505853A (en) 1991-07-05 1994-11-14 Serum:plasma separator and tube for the separation of serum:plasma from clot:hemocyte

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3268746A JP2943454B2 (en) 1991-09-20 1991-09-20 Blood separation agent and blood separation tube

Publications (2)

Publication Number Publication Date
JPH0580044A true JPH0580044A (en) 1993-03-30
JP2943454B2 JP2943454B2 (en) 1999-08-30

Family

ID=17462765

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3268746A Expired - Fee Related JP2943454B2 (en) 1991-07-05 1991-09-20 Blood separation agent and blood separation tube

Country Status (1)

Country Link
JP (1) JP2943454B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001108671A (en) * 1999-08-20 2001-04-20 Stephen C Wardlaw Method for separating molding component from liquid component of composite organism fluid sample and assembly

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56166956A (en) * 1980-05-26 1981-12-22 Terumo Corp Liquid separating agent
JPH01295163A (en) * 1987-12-28 1989-11-28 Sekisui Chem Co Ltd Composition for separating serum or plasma
JPH0295257A (en) * 1988-09-30 1990-04-06 Sekisui Chem Co Ltd Composition for separation of blood component and vessel for blood inspection
JPH02290553A (en) * 1989-02-22 1990-11-30 Becton Dickinson & Co Composite for blood separation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56166956A (en) * 1980-05-26 1981-12-22 Terumo Corp Liquid separating agent
JPH01295163A (en) * 1987-12-28 1989-11-28 Sekisui Chem Co Ltd Composition for separating serum or plasma
JPH0295257A (en) * 1988-09-30 1990-04-06 Sekisui Chem Co Ltd Composition for separation of blood component and vessel for blood inspection
JPH02290553A (en) * 1989-02-22 1990-11-30 Becton Dickinson & Co Composite for blood separation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001108671A (en) * 1999-08-20 2001-04-20 Stephen C Wardlaw Method for separating molding component from liquid component of composite organism fluid sample and assembly

Also Published As

Publication number Publication date
JP2943454B2 (en) 1999-08-30

Similar Documents

Publication Publication Date Title
EP0028909B1 (en) Thixotropic agent and compositions incorporating it
CN103946333B (en) Hot melt bottle labeling binder containing vaseline
EP0861285B1 (en) A polymeric composition in pellet form
US4699938A (en) Pressure-sensitive adhesive composition
JP2605156B2 (en) Solid non-aqueous hot melt adhesive composition, solid non-aqueous powder coating composition, solid non-aqueous heat-reactive delayed tack composition and solid non-aqueous thermoplastic composition
US3232895A (en) Adhesive compositions comprising ethylene/vinyl acetate, chlorinated paraffin, and rosin
CN110088217A (en) Rubber-based multi-layer pressure-sensitive adhesive component with low VOC feature
WO1998024861A1 (en) Hot-melt adhesive composition with excellent heat and cold resistance
JP2002512559A (en) Thermoplastic adsorbent composition containing wax and insulating glass unit containing such composition
JP2003292722A (en) Composition, process for preparing the same, process for sticking two surfaces to each other, and product produced thereby
JPH0580044A (en) Blood separation agent and blood separation tube
JP3904376B2 (en) Blood separation agent and blood separation tube
CN1745155A (en) Packaging tape adhesive composition and packaging tape comprising it
US4432848A (en) Radiation cured, high temperature pressure-sensitive adhesive
US5505853A (en) Serum:plasma separator and tube for the separation of serum:plasma from clot:hemocyte
US4048424A (en) Novel hydrocarbon resins and process for preparation thereof
JPS5938275B2 (en) Thermoplastic rubber adhesive composition
JP3303369B2 (en) Blood separation agent and blood separation tube
JPH08506838A (en) Method for packaging adhesive composition and packaging composition
JPS5813594B2 (en) Pressure-sensitive heat-melt adhesive composition
JP2943420B2 (en) Blood separation agent and blood separation tube
EP0521733B1 (en) Serum:plasma separator and tube containing the same
JPH06148174A (en) Blood separating agent and blood separating tube
JPH0665446A (en) Carrier for oily substance
JP3077470B2 (en) Blood separation agent and blood separation tube using the same

Legal Events

Date Code Title Description
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110625

Year of fee payment: 12

LAPS Cancellation because of no payment of annual fees